What is the treatment for treatment-resistant poison ivy using steroid (corticosteroid) injections, specifically triamcinolone acetonide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Treatment-Resistant Poison Ivy with Steroid Injection

For treatment-resistant poison ivy dermatitis, intralesional triamcinolone acetonide injections (5-10 mg/mL) administered just beneath the dermis in the upper subcutis can effectively resolve inflammation when other treatments have failed. 1

Approach to Treatment-Resistant Poison Ivy

First-Line Treatments (Before Considering Injections)

  • High-potency topical corticosteroids (clobetasol propionate 0.05% or betamethasone dipropionate 0.05%) applied twice daily for up to 2 weeks 1
  • Oral prednisone 0.5-1 mg/kg/day for extensive disease (>30% BSA) or severe reactions, most effective when started within 48 hours of rash onset 1
  • Symptomatic measures including cool compresses, oatmeal baths, and oral antihistamines for pruritus 1

When to Consider Intralesional Steroid Injections

Intralesional corticosteroid injections should be considered when:

  • Topical and oral treatments have failed
  • The reaction is localized to specific areas
  • The patient has persistent, severe symptoms despite standard therapy

Intralesional Injection Technique

Medication and Dosage

  • Triamcinolone acetonide 5-10 mg/mL is the preferred agent 2
  • Hydrocortisone acetate 25 mg/mL can be used as an alternative 2

Administration Method

  • Inject 0.05-0.1 mL just beneath the dermis in the upper subcutis 2
  • Each injection will treat approximately a 0.5 cm diameter area 2
  • Multiple injections may be given to cover the affected area, limited primarily by patient discomfort 2
  • Alternatively, a needleless device (e.g., Dermajet) can be used to administer the medication 2

Expected Results

  • Effects typically last about 9 months based on studies in other dermatologic conditions 2
  • Studies have shown up to 62% of patients achieve full resolution with monthly injections of triamcinolone acetonide 2

Important Considerations and Precautions

Side Effects and Risks

  • Skin atrophy at the injection site is a consistent side effect, particularly with triamcinolone 2
  • Pain during injection is common and may limit the number of injections that can be administered 2
  • Potential for systemic absorption, though minimal compared to oral steroids

Contraindications

  • Suspected infection at the injection site
  • History of hypersensitivity to corticosteroids
  • Caution in patients with diabetes, hypertension, or peptic ulcer disease 1

Follow-up Care

  • Evaluate response within 1-2 weeks after injection
  • Consider repeat injections for persistent areas
  • Continue supportive care measures including antihistamines for pruritus and cool compresses 1

Alternative Approaches for Refractory Cases

If intralesional injections fail or are not appropriate:

  • Consider patch testing to confirm diagnosis if uncertain 3
  • For extensive disease, a longer course of oral prednisone (15 days total) may be beneficial compared to short courses, as it reduces the need for additional medications 4
  • Referral to dermatology for specialized treatments may be necessary in extremely resistant cases

Remember that poison ivy dermatitis is typically self-limiting within 2-3 weeks 5, but treatment-resistant cases can cause significant discomfort and may require more aggressive intervention with intralesional steroids to provide relief and prevent prolonged suffering.

References

Guideline

Poison Ivy Dermatitis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of contact dermatitis.

American family physician, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.